What is the diagnosis and appropriate management for a patient presenting with low potassium, low sodium, elevated aldosterone, and a high aldosterone-to-renin ratio?

Primary Aldosteronism: Diagnosis and Management

This presentation of low potassium, low sodium (though typically sodium is retained/normal-high in PA), elevated aldosterone, and high aldosterone-to-renin ratio (aldo/PRA ratio) is diagnostic of primary aldosteronism (PA), and you should proceed immediately with confirmatory testing followed by adrenal vein sampling to determine lateralization for potential surgical cure.

Diagnostic Confirmation

The biochemical picture you describe is classic for PA 1. The aldosterone-to-renin ratio >30 (when aldosterone is in ng/dL and PRA in ng/mL/h) with suppressed renin and elevated aldosterone confirms screening positivity 2, 1. However, guidelines mandate confirmatory testing before proceeding to subtype classification 1, 3.

Confirmatory Testing Options

Perform one of the following 2, 1:

• Saline infusion test: 2L normal saline IV over 4 hours; PA confirmed if aldosterone fails to suppress below 280 pmol/L (or <10 ng/dL)
• Oral sodium loading: 300 mmol sodium daily for 3 days; PA confirmed if aldosterone fails to suppress below 240 pmol/L
• Fludrocortisone suppression test: Oral sodium loading plus fludrocortisone 0.25 mg daily for 2 days; positive if aldosterone ≥140 pmol/L

Important caveat: Correct hypokalemia to normal range before confirmatory testing, as low potassium can falsely suppress aldosterone levels 3. Withdraw mineralocorticoid receptor antagonists (spironolactone, eplerenone) for at least 4 weeks before testing 1.

Subtype Classification: The Critical Decision Point

Once PA is confirmed, adrenal vein sampling (AVS) is the gold standard for distinguishing unilateral from bilateral disease 2. This distinction is absolutely critical because it determines whether the patient gets cured surgically or requires lifelong medical therapy.

When AVS Can Be Skipped

You may reasonably skip AVS only in these specific scenarios 2:

• Patient <35-40 years old with unilateral adenoma on CT/MRI and overt biochemical PA
• Suspicion of adrenal malignancy (irregular morphology, lipid-poor, >3 cm, doesn't wash out on contrast CT)
• Patient refuses surgery or has surgical contraindications

CT/MRI alone is unreliable for lateralization because nonfunctioning incidentalomas are common and functional adenomas can be small 2.

Treatment Algorithm

For Unilateral Disease (Confirmed by AVS)

Laparoscopic adrenalectomy is the treatment of choice 2, 1, 2. This approach:

• Improves blood pressure in virtually 100% of patients
• Cures hypertension completely in approximately 50% 1, 4
• Resolves hypokalemia
• Eliminates aldosterone-mediated cardiovascular and renal damage

For Bilateral Disease or Non-Surgical Candidates

Mineralocorticoid receptor antagonists are first-line medical therapy 2, 5, 6:

Spironolactone dosing 5:

• Start: 12.5-25 mg daily (single morning dose)
• Titrate gradually every 2-3 months as needed
• Maximum: 100 mg daily
• Side effects are dose-dependent: gynecomastia occurs in 6.9% at <50 mg/day but 52% at >150 mg/day 5

Eplerenone alternative 5:

• Start: 25 mg twice daily
• More selective MR antagonist with fewer endocrine side effects
• 50% of the potency of spironolactone, requiring higher doses
• Higher cost but better tolerability profile

Critical monitoring: Use caution with stage III CKD (GFR <60 mL/min/1.73 m²) due to hyperkalemia risk; avoid in stage IV disease 5.

Why This Matters for Morbidity and Mortality

PA is not just about blood pressure control. Aldosterone excess causes specific cardiovascular and renal damage independent of hypertension 1. Patients with PA have:

• Higher rates of left ventricular hypertrophy
• Increased cardiovascular events compared to essential hypertension at similar BP levels
• Progressive renal injury with declining GFR and albuminuria
• Higher stroke risk, particularly in young patients

Both surgical and medical PA-specific treatments reverse these complications 1, 4, which is why identifying and treating PA specifically (rather than just treating hypertension with standard agents) improves outcomes.

Common Pitfalls to Avoid

1. Don't rely on hypokalemia for diagnosis: The majority of PA patients are normokalemic 1. Hypokalemia has low negative predictive value.

2. Don't skip confirmatory testing: The screening ARR can have false positives, particularly with very low renin levels 1.

3. Don't use CT alone for lateralization: Proceed to AVS in surgical candidates unless they meet specific exceptions noted above 2.

4. Don't forget to correct potassium before testing: This can lead to false-negative results 3.

5. Watch for unmasking of renal dysfunction: Treating PA (surgically or medically) frequently reveals underlying reduced GFR that was disguised by aldosterone-induced hyperfiltration 5.